Nautilus Biotechnology, Inc.
NAUT
$1.04
$0.032.97%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -14.47M | -14.70M | -13.78M | -13.57M | -15.03M |
| Total Depreciation and Amortization | 1.28M | 1.48M | 1.59M | 1.62M | 1.63M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.17M | 1.29M | 1.34M | 1.19M | 1.27M |
| Change in Net Operating Assets | -1.71M | -1.17M | -1.52M | -269.00K | -1.22M |
| Cash from Operations | -13.73M | -13.10M | -12.38M | -11.03M | -13.35M |
| Capital Expenditure | -454.00K | -510.00K | -244.00K | -418.00K | -396.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 12.48M | 14.74M | 1.03M | 870.00K | 14.87M |
| Cash from Investing | 12.02M | 14.23M | 787.00K | 452.00K | 14.47M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 244.00K | 1.11M | 101.00K | 0.00 | 95.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 244.00K | 1.11M | 101.00K | 0.00 | 95.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.46M | 2.24M | -11.49M | -10.58M | 1.22M |